Integrating artificial intelligence with circulating tumor DNA for non-small cell lung cancer: opportunities, challenges, and future directions

Integrating artificial intelligence with circulating tumor DNA for non-small cell lung cancer: opportunities, challenges, and future directions

Non-small cell lung cancer (NSCLC) remains a leading cause of cancer mortality, with late-stage diagnosis contributing to poor survival. Circulating tumor DNA (ctDNA) has emerged as a non-invasive biomarker for screening, diagnosis, and monitoring, with limitations about sensitivity and specificity...

Full description

Saved in:
Bibliographic Details
Main Authors: Nishanth Thalambedu, Mamtha Balla, Barath Prashanth Sivasubramanian, Prasanth Sadaram, Krishna Prathiba Malla, Krishna P. Vasipalli, Sunil Kakadia
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-06-01
Series:Frontiers in Medicine
Subjects:
lung cancer
screening
minimal residual disease
circulating tumor DNA
artificial intelligence
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2025.1612376/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2025.1612376/full

Similar Items